BIOMARIN PHARMACEUTICAL INC (BMRN) Net Income (Loss) Attributable to Parent USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
  • Biomarin Pharmaceutical Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was $88.7 M, a 74.4% increase year-over-year.
  • Biomarin Pharmaceutical Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was $205 M, a 187% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Net Income (Loss) Attributable to Parent for 2023 was $168 M, a 18.4% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Net Income (Loss) Attributable to Parent for 2022 was $142 M.
  • Biomarin Pharmaceutical Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$64.1 M, a 108% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $205 M $88.7 M +$37.8 M +74.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $168 M $20.4 M +$20.6 M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $147 M $40.4 M +$47 M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $100 M $56 M +$28.4 M +103% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $71.6 M $50.9 M -$69.9 M -57.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $142 M -$249 K +$57.6 M +99.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $83.9 M -$6.65 M +$29.8 M +81.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $54.1 M $27.7 M +$14.7 M +114% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $39.3 M $121 M +$103 M +595% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 -$64.1 M -$57.9 M -$74.9 M -440% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $10.8 M -$36.5 M -$821 M -105% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $832 M $12.9 M +$42.1 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $790 M $17.4 M -$64 M -78.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $854 M $17 M +$2 M +13.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $852 M $785 M +$730 M +1326% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $122 M -$29.2 M +$8.25 M +22% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $114 M $81.4 M +$138 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 -$23.8 M $15 M +$18.7 M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 -$42.5 M $55 M +$67.7 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$110 M -$37.4 M -$20.6 M -123% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$89.5 M -$56.5 M -$12.3 M -27.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 -$77.2 M -$3.65 M +$47.7 M +92.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 -$125 M -$12.6 M -$93 K -0.74% Jul 1, 2018 Sep 30, 2018 10-Q/A 2019-11-04
Q2 2018 -$125 M -$16.8 M +$20 M +54.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 -$145 M -$44.1 M -$27.9 M -171% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 -$117 M -$51.4 M +$39.3 M +43.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$156 M -$12.5 M +$24.9 M +66.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 -$181 M -$36.8 M +$382 M +91.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$563 M -$16.3 M +$66.8 M +80.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 -$630 M -$90.7 M -$159 M -232% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$471 M -$37.4 M +$53.5 M +58.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 -$524 M -$419 M -$337 M -411% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 -$187 M -$83.1 M -$15.6 M -23% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$172 M $68.6 M +$138 M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 -$310 M -$90.9 M -$98.4 M -1321% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$212 M -$82 M -$48.5 M -145% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$163 M -$67.5 M -$29.4 M -77.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 -$134 M -$69.8 M -$7.81 M -12.6% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 -$126 M $7.45 M +$60.5 M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 -$187 M -$33.5 M -$12 M -55.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 -$175 M -$38.1 M +$1.7 M +4.26% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 -$176 M -$62 M -$8.98 M -16.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 -$167 M -$53 M -$47.7 M -890% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 -$120 M -$21.5 M +$10.5 M +32.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 -$130 M -$39.8 M -$15.8 M -66.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 -$114 M -$53 M -$26.3 M -98.3% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 -$88.1 M -$5.36 M +$12.3 M +69.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 -$100 M -$32 M -$26.9 M -530% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-29
Q1 2012 -$73.4 M -$24 M -$19.6 M -448% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-29
Q4 2011 -$53.8 M -$26.7 M -$14.5 M -119% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-26
Q3 2011 -$39.3 M -$17.7 M -$235 M -108% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-29
Q2 2011 $196 M -$5.08 M -$4.6 M -964% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-02
Q1 2011 $200 M -$4.37 M -$5.52 M -480% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-30
Q4 2010 $206 M -$12.2 M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 $217 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 -$477 K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-01
Q1 2010 $1.15 M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.